ACE2 and pancreatic adenocarcinoma: ACE2, the vital entry receptor for SARS‐CoV‐2, is overexpressed in certain tumors such as colon adenocarcinoma, renal carcinomas, pancreatic adenocarcinoma, and lung adenocarcinoma, potentially increasing viral susceptibility.